DOH HIV/AIDS-Related Issuances
DOH HIV / AIDS-Related Issuances
| Title | Issuance Number | Date |
| Study Tour on HIV/AIDS Policy of the International Center for Development Communication (ICDC) on 12-19 June 2014 at the Kasetsart University, Bangkok, Thailand | DC 2014-0037 | February 04, 2014 |
| Gender and Development Course of the International Center for Development Communication (ICDC) on 16-26 September 2014 at Kasetsart University, Bangkok, Thailand | DC 2014-0184 | May 07, 2014 |
| 2014 Philippine National Conference and Meeting on Sexual Orientation, Gender Identity and Expression (SOGIE) and the HIV AIDS Training of the Ladlad Caraga, Inc. on 07-10 August 2014 at Dottie's Place Hotel and Restaurant, Butuan City. | DC 2014-0236 | June 10, 2014 |
| 11th Biennial Convention of the Philippine Society of Venereologists, Inc. on September 18-19, 2014 at the MK Tan Hall, Bayanihan Center UNILAB, Mandaluyong City | DC 2014-0301 | July 25,2014 |
| Initiation of Philippine Antiretroviral (ARV) Drug Resistance Surveillance | DC 2015-0101 | March 25, 2015 |
| 11th Post Graduate Course entitled "Hot Topics & Challenge in STI's of the Philippine Society of Venereologist, Inc. (PSV) on September 17-18, 2015 at PMA Auditorium in Quezon City and San Lazaro Hospital Amphitheater, San Lazaro, Sta. Cruz, Manila | DC 2015-0245 | July 27, 2015 |
| Enhancing Linkage to Care of People Living with HIV (PLHIV) | DC 2016-0171 | June 7, 2016 |
| 14th Philippine National Convention on AIDS of the AIDS Society of the Philippines Inc. on October 6-7, 2016 at the Manansala Ballroom, The Saulo Riviera Hotel, Matalino Road, Diliman, Quezon City | DC 2016-0281 | October 3, 2016 |
| Clinical Practice Guidelines for the Prevention, Diagnosis and Treatment of Opportunistic Infections in Human Immunodeficiency Virus-Infected Adults and Adolescents in the Philippines 2016 | DC 2017-0165 | April 17, 2017 |
| National HIV/AIDS and STI Program (NASPCP) Recommendations for Testing, Diagnosis and Treatment of Chronic Hepatitis C among People Living with Human Immunodeficiency Virus (PLHIV) | DC 2017-0273 | August 9, 2017 |
| Reporting Forms for HIV Testing, HIV Care and Treatment and Mortality | MC 2017-0021 | June 14, 2017 |
| Submission of Antiretroviral Therapy (ART) Forms and Masterlist | MC 2015-0003 | January 9, 2015 |
| Revision of the Reporting System for the Newly Diagnosed People Living with HIV (PLHIV), Baseline Assessment for Art Eligibility, HIV Care, Treatment, and Mortality in Accordance with the New National Art and TB-HIV Guidelines | MC 2015-0002 | January 9, 2015 |
| Manual of Operations for the National HIV/AIDS Registry | MC 2006-0075 | October 25, 2006 |
| Guidelines on Access and Utilization on Anti-retroviral (ARV) Drugs Procured Through the Global Fund to Fight AIDS Tuberculosis and Malaria (GFATM) for HIV/AIDS Patients from Six Treatment Centers | MC 2006-0026 | April 24, 2006 |
| Guidelines on Out-Patient Department Consultation and/or Hospitalization of HIV/AIDS Patients | MC 51-A s. 1994 | April 11, 1994 |
| Guidelines on Out-Patient Department Consultation and/or Hospitalization of HIV/AIDS Patients | DC 2017-0321 | October 13, 2017 |
| Guidelines on the Implementation of Rapid HIV Diagnostic Algorithm (rHIVda) | AO 2019-0001 | January 10, 2019 |
| Implementing Rules and Regulations (IRR) of Republic Act No. 11166 entitled “Philippine HIV and AIDS Policy Act” | MC 2019-0038 | September 18, 2019 |
| Post Graduate Course Conference of the Philippine Society of Venereology on October 10-11, 2019 | DC 2019-0486 | October 14, 2019 |
| Guidelines in Securing a License to Operate a Certified rHIVda Confirmatory Laboratory (CrCL) | DC 2019-0497 | May 29, 2019 |
| Guidelines in Securing a License to Operate a Certified rHIVda Confirmatory Laboratory (CrCL) | AO 2019-0051 | November 8, 2019 |
| Global Experts Meeting on STD AIDS and Infectious Diseases of the Allied Academies LLC on November 21-22, 2019 | DC 2019-0546 | November 8, 2019 |
| Inclusion of Tenofovir/Lamivudine/Dolutegravir (TLD) in the Philippine National Formulary (PNF) | DC 2021-0400 | September 1, 2021 |
| Implementation and Dissemination of the Human Immunodeficiency Virus (HIV) Adaptive Plan | DC 2021-0507 | October 27, 2021 |
| Oral PrEP (Emtricitabine 200mg FDC + Tenofovir Disoproxil Fumarate 300 mg) in the Philippine National Formulary (PNF) | DC 2022-0044 | January 20, 2022 |
| Guidelines on Tuberculosis - Human Immunodeficiency Virus (TB-HIV) Services Integration for Universal Health Care (UHC) Implementation | AO 2022-0010 | March 25, 2022 |
| Guidelines on Differentiated Treatment for People Living with Human Immunodeficiency Virus (PLHIV) and Prophylaxis for HIV-Exposed Infants | AO 2022-0024 | March 25, 2022 |
| Guidelines in the Implementation of Differentiated HIV Testing Services | AO 2022-0035 | August 22, 2022 |
| Updated Directory of DOH-Designated Human Immunodeficiency Virus (HIV) Treatment Hubs and Primary HIV Care Facilities in the Philippines as of May 30, 2023 | DC 2023-0284 | June 15, 2023 |
| Interim Guidelines in the Regulation of Confirmatory Rapid HIV Diagnostic Algorithm Clinical Laboratory (CrCL) | DC 2023-0291 | June 05, 2023 |
